These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17518124)

  • 1. The FDA, stocks, black boxes and ESAs.
    Spry L
    Nephrol News Issues; 2007 May; 21(6):53-4. PubMed ID: 17518124
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing anemia: what do we do now?
    Neumann ME
    Nephrol News Issues; 2007 May; 21(6):50, 52. PubMed ID: 17518123
    [No Abstract]   [Full Text] [Related]  

  • 3. The FDA black box for EPO: what should nephrologists do?
    Singh AK
    Nephrol News Issues; 2007 May; 21(6):55-6, 58-9. PubMed ID: 17518125
    [No Abstract]   [Full Text] [Related]  

  • 4. Reaction from renal associations. Renal Physicians Association.
    Blaser R
    Nephrol News Issues; 2007 May; 21(6):61-2, 64. PubMed ID: 17518126
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety concerns for two big anemia drugs.
    Nursing; 2008 Oct; 38(10):12. PubMed ID: 18812980
    [No Abstract]   [Full Text] [Related]  

  • 6. Rebates for anti-anemia drugs draw response from FDA, CMS.
    Sipkoff M
    Manag Care; 2007 Jun; 16(6):17-8. PubMed ID: 17682732
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythropoietin, the FDA, and oncology.
    Steinbrook R
    N Engl J Med; 2007 Jun; 356(24):2448-51. PubMed ID: 17568025
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA finalizes REMS program for ESAs; Amgen continues to study risks.
    Brower V
    J Natl Cancer Inst; 2010 May; 102(9):592-3. PubMed ID: 20421565
    [No Abstract]   [Full Text] [Related]  

  • 9. ESAs further restricted, but debate continues.
    Brower V
    J Natl Cancer Inst; 2008 Oct; 100(19):1344-51. PubMed ID: 18812542
    [No Abstract]   [Full Text] [Related]  

  • 10. Reimbursement for erythropoiesis-stimulating agents poses challenges.
    Traynor K
    Am J Health Syst Pharm; 2008 Mar; 65(5):385-6. PubMed ID: 18281727
    [No Abstract]   [Full Text] [Related]  

  • 11. Anemia management under a bundled payment policy for dialysis: a preview for the United States from Japan.
    Wish JB
    Kidney Int; 2011 Feb; 79(3):265-7. PubMed ID: 21228798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reevaluating erythropoiesis-stimulating agents.
    Cotter DJ
    N Engl J Med; 2010 May; 362(18):1743; author reply 1743-4. PubMed ID: 20449881
    [No Abstract]   [Full Text] [Related]  

  • 13. Full results on risks of epoetin emerge 14 years after major dialysis study.
    Epstein K
    BMJ; 2012 May; 344():e3535. PubMed ID: 22619221
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythropoietin: the swinging pendulum.
    Oster HS; Neumann D; Hoffman M; Mittelman M
    Leuk Res; 2012 Aug; 36(8):939-44. PubMed ID: 22579365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taking a subq approach to EPO: experience in the clinic.
    Wish J
    Nephrol News Issues; 2007 Oct; 21(11):68. PubMed ID: 17970511
    [No Abstract]   [Full Text] [Related]  

  • 16. Biosimilar epoetins.
    Macdougall IC
    Nephrol Dial Transplant; 2009 May; 24(5):1698-9; author reply 1699-700. PubMed ID: 19366858
    [No Abstract]   [Full Text] [Related]  

  • 17. Weighing the hazards of erythropoiesis stimulation in patients with cancer.
    Khuri FR
    N Engl J Med; 2007 Jun; 356(24):2445-8. PubMed ID: 17568023
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythropoietin claims monitoring policy: implications for clinical practice.
    Messana T
    Nephrol Nurs J; 2006; 33(2):209-13, 222; quiz 214-5. PubMed ID: 16613415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA panel scrutinizes safety of anti-anemia drugs.
    Randal J
    J Natl Cancer Inst; 2004 Jul; 96(14):1061. PubMed ID: 15265966
    [No Abstract]   [Full Text] [Related]  

  • 20. Reevaluating erythropoiesis-stimulating agents.
    Kestenbaum B
    N Engl J Med; 2010 May; 362(18):1742; author reply 1743-4. PubMed ID: 20445190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.